Invion (ASX:IVX) Accounts Payable & Accrued Expense : A$0.62 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Invion Accounts Payable & Accrued Expense?

Invion's quarterly accounts payable & accrued expense increased from Dec. 2023 (A$0.42 Mil) to Jun. 2024 (A$0.93 Mil) but then declined from Jun. 2024 (A$0.93 Mil) to Dec. 2024 (A$0.62 Mil).

Invion's annual accounts payable & accrued expense increased from Jun. 2022 (A$0.42 Mil) to Jun. 2023 (A$0.59 Mil) and increased from Jun. 2023 (A$0.59 Mil) to Jun. 2024 (A$0.93 Mil).

Invion Accounts Payable & Accrued Expense Historical Data

The historical data trend for Invion's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion Accounts Payable & Accrued Expense Chart

Invion Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.28

0.84

0.42

0.59

0.93

Invion Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.60	0.59	0.42	0.93	0.62

Invion Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Invion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (ASX:IVX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

7C8:Germany

Address

692 High Street, East Kew, VIC, AUS, 3102

Website

https://www.inviongroup.com

Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines